normative
Humira Profits Reflect Incentives, Not Unfairness
Humira's roughly $20 billion in annual revenue looks unreasonable in isolation, but it must be judged in the system of incentives, because the rare huge winners are required to fund the many failures in drug development.
normativepending
Speaker
AlexEvidence Quote
“you can say it just seems unreasonable that anyone is making $20 billion off this drug per year. ... But you have to think more about the system of incentives.”
Source
Alex Telford - Unlocking Innovation in Pharma - [Invest Like the Best, EP.360]— Invest Like the BestCreated: 11/14/2026, 6:42:06 AM
Your notes
Loading notes...